Is anyone who is NOT diabetic taking any GLP-1 receptor agonists (GLP-1s) anti-obesity medications like Dulaglutide (Trulicity), Exenatide (Byetta, Bydureon), Liraglutide (Victoza, Saxenda), Lixisenatide (Adlyxin), Semaglutide (Ozempic, Wegovy, Rybelsus), and Tirzepatide (Mounjaro, Zepbound) to reduce obesity and thus, reduce risk of multiple myeloma progession? Or, do you know of any Trials looking at GLP-1's and MGUS, SMM or MM?